Figure 2.
Figure 2. Cumulative risk of second malignancy following high-dose chemotherapy and autologous stem cell transplantation for Hodgkin lymphoma.

Cumulative risk of second malignancy following high-dose chemotherapy and autologous stem cell transplantation for Hodgkin lymphoma.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal